INS and obesity due to melanocortin 4 receptor deficiency: One study demonstrated that in patients living with obesity and T2DM, 18% weight loss achieved either by RYGB or caloric restriction resulted in similar improvements in insulin sensitivity and β-cell function, suggesting that metabolic improvements are weight-related [44].